Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010The Lancet (British edition), 2013-11, Vol.382 (9904), p.1575-1586 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 9, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61611-6 ;PMID: 23993280 ;CODEN: LANCAOFull text available |
|
2 |
Material Type: Article
|
Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trialThe Lancet (British edition), 2011-07, Vol.378 (9785), p.49-55 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 2-Jul 8, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60701-0 ;PMID: 21722952 ;CODEN: LANCAOFull text available |
|
3 |
Material Type: Article
|
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet (British edition), 2012-06, Vol.379 (9834), p.2352-2363 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 23-Jun 29, 2012 ;2012 Elsevier Ltd. All rights reserved. 2012 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60768-5 ;PMID: 22632908 ;CODEN: LANCAOFull text available |
|
4 |
Material Type: Article
|
Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyThe Lancet infectious diseases, 2019-11, Vol.19 (11), p.1209-1218 [Peer Reviewed Journal]2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(19)30446-3 ;PMID: 31519541Full text available |
|
5 |
Material Type: Article
|
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational journal of cancer, 2019-04, Vol.144 (8), p.1941 [Peer Reviewed Journal]2018 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.31937 ;PMID: 30350310Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialThe Lancet (British edition), 2021-05, Vol.397 (10285), p.1637-1645 [Peer Reviewed Journal]2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2021. Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Published by Elsevier Ltd. All rights reserved. This is an Open Access article under the CC BY 4.0 license 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00676-0 ;PMID: 33933206Full text available |
|
7 |
Material Type: Article
|
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsThe lancet oncology, 2020-04, Vol.21 (4), p.531-540 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30856-3 ;PMID: 32105622Full text available |
|
8 |
Material Type: Article
|
Impacts of the COVID-19 pandemic on rural AmericaProceedings of the National Academy of Sciences - PNAS, 2021-01, Vol.118 (1), p.1 [Peer Reviewed Journal]Copyright National Academy of Sciences Jan 5, 2021 ;2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2019378118 ;PMID: 33328335Full text available |
|
9 |
Material Type: Article
|
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage studyThe Lancet (British edition), 2022-01, Vol.399 (10323), p.437-446 [Peer Reviewed Journal]2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. 2022 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00017-4 ;PMID: 35065011Full text available |
|
10 |
Material Type: Article
|
GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial DysfunctionPloS one, 2016-02, Vol.11 (2), p.e0148709-e0148709 [Peer Reviewed Journal]COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Montero et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;cc-by (c) Montero, Raquel et al., 2016 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es ;2016 Montero et al 2016 Montero et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0148709 ;PMID: 26867126Full text available |
|
11 |
Material Type: Article
|
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort studyThe Lancet infectious diseases, 2022-01, Vol.22 (1), p.35-42 [Peer Reviewed Journal]2022 ;Crown copyright © 2022 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Jan 2022 ;Crown Copyright © 2021 Published by Elsevier Ltd. 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00475-8 ;PMID: 34461056Full text available |
|
12 |
Material Type: Article
|
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trialThe Lancet (British edition), 2011-10, Vol.378 (9802), p.1547-1559 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 29-Nov 4, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61383-4 ;PMID: 21908036 ;CODEN: LANCAOFull text available |
|
13 |
Material Type: Article
|
Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)The Lancet (British edition), 2015-03, Vol.385 (9972), p.977-1010 [Peer Reviewed Journal]Allemani et al. Open Access article distributed under the terms of CC BY ;2015 Allemani et al. Open Access article distributed under the terms of CC BY ;Copyright © 2015 Allemani et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 14, 2015 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)62038-9 ;PMID: 25467588 ;CODEN: LANCAOFull text available |
|
14 |
Material Type: Article
|
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19New England Journal of Medicine, 2021-10, Vol.385 (15), p.1382-1392 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102685 ;PMID: 34260849Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Duration of Protection against Mild and Severe Disease by Covid-19 VaccinesNew England Journal of Medicine, 2022-01, Vol.386 (4), p.340-350 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2115481 ;PMID: 35021002Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance studyJournal of cardiovascular magnetic resonance, 2014-10, Vol.16 (1), p.69-69, Article 69 [Peer Reviewed Journal]COPYRIGHT 2014 BioMed Central Ltd. ;COPYRIGHT 2014 BioMed Central Ltd. ;2014 Dabir et al.; licensee BioMed Central Ltd. ;Dabir et al.; licensee BioMed Central Ltd. 2014 ;ISSN: 1532-429X ;ISSN: 1097-6647 ;EISSN: 1532-429X ;DOI: 10.1186/s12968-014-0069-x ;PMID: 25384607Full text available |
|
17 |
Material Type: Article
|
Common variants near MC4R are associated with fat mass, weight and risk of obesityNature genetics, 2008-06, Vol.40 (6), p.768-775 [Peer Reviewed Journal]2008 INIST-CNRS ;COPYRIGHT 2008 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2008 ;2008 Nature Publishing Group 2008 ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/ng.140 ;PMID: 18454148 ;CODEN: NGENECFull text available |
|
18 |
Material Type: Article
|
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational studyThe Lancet (British edition), 2021-03, Vol.397 (10280), p.1204-1212 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00575-4 ;PMID: 33743221Full text available |
|
19 |
Material Type: Article
|
Surveillance for Adverse Events After COVID-19 mRNA VaccinationJAMA : the journal of the American Medical Association, 2021-10, Vol.326 (14), p.1390 [Peer Reviewed Journal]EISSN: 1538-3598 ;DOI: 10.1001/jama.2021.15072 ;PMID: 34477808Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorderNature genetics, 2019-01, Vol.51 (1), p.63-75 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2019 ;info:eu-repo/semantics/openAccess ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-018-0269-7 ;PMID: 30478444Full text available |